Stay updated on Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Metastatic Breast Cancer Clinical Trial page.

Latest updates to the Metastatic Breast Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page reflects a minor platform patch from v3.6.3 to v3.6.4, with no changes to the study details or other content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision tag v3.6.3 was added and the previous tag v3.6.2 was removed, indicating a minor maintenance update to the page rather than a change to study content.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page’s keyword and MeSH term lists were expanded to include several drugs and disease-related terms (e.g., Paclitaxel, Trastuzumab/Herceptin, CT-P6, Her 2-positive, metastatic breast cancer) as well as related chemical categories and record-keeping terms. This metadata update enhances indexing and searchability without modifying the study details themselves.SummaryDifference49%

- Check52 days agoChange DetectedThe page now shows that enrollment has ended. Additionally, new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, along with a revision note (Revision: v3.6.0) and a new Intervention/Treatment heading.SummaryDifference0.5%

- Check59 days agoChange DetectedRevision: v3.5.5 was added, replacing the previous Revision: v3.5.4. This reflects a newer version of the page's documentation and metadata rather than substantive content changes.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4 in the study record. This reflects a software/UI update to the page metadata rather than changes to the trial information.SummaryDifference0.1%

Stay in the know with updates to Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Metastatic Breast Cancer Clinical Trial page.